Case Report
Published on 14 Mar 2023
Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1066083
- 1,494 views
- 1 citation
Type at least 3 characters
1,748 articles
Articles
Original Research
Published on 14 Mar 2023
NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1146029
- 1,297 views
- 1 citation
Review
Published on 14 Mar 2023
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1152467
- 2,664 views
- 1 citation
Original Research
Published on 10 Mar 2023
Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1110693
- 3,089 views
- 2 citations
Review
Published on 10 Mar 2023
LSD1 inhibition modulates transcription factor networks in myeloid malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1149754
- 4,837 views
- 2 citations
Brief Research Report
Published on 10 Mar 2023
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1120967
- 3,922 views
- 2 citations
Editorial
Published on 09 Mar 2023
Editorial: Advances in the treatment of chronic myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1166588
- 2,493 views
Original Research
Published on 09 Mar 2023
A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1143556
- 1,648 views
- 1 citation
Editorial
Published on 08 Mar 2023
Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1166163
- 1,082 views
- 1 citation
Original Research
Published on 07 Mar 2023
Replication stress increases mitochondrial metabolism and mitophagy in FANCD2 deficient fetal liver hematopoietic stem cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1108430
- 2,279 views
Brief Research Report
Published on 07 Mar 2023
Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1128994
- 4,590 views
- 8 citations
Perspective
Published on 07 Mar 2023
Treatment selection for patients with relapsed or refractory follicular lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1120358
- 4,996 views
- 1 citation
Original Research
Published on 06 Mar 2023
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1133418
- 2,080 views
- 5 citations
Review
Published on 03 Mar 2023
Advances in the treatment of Hodgkin lymphoma: Current and future approaches
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1067289
- 10,222 views
- 11 citations
Case Report
Published on 02 Mar 2023
Case report: Ruxolitinib plus dexamethasone as first-line therapy in haemophagocytic lymphohistiocytosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1054175
- 1,720 views
- 3 citations
Editorial
Published on 28 Feb 2023
Editorial: Advances in the treatment of Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1164081
- 1,452 views